**Author details**

Said M. Yaiesh1 \*, Abdullatif E. Al-Terki2 and Tariq F. Al-Shaiji<sup>2</sup>

1 Mubarak Al-Kabeer Hospital, Kuwait City, Kuwait

2 Amiri Hospital, Kuwait City, Kuwait

\*Address all correspondence to: syaiesh@hotmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**235**

*Neuromodulation in Urology: Current Trends and Future Applications*

[9] Powell CR. Neuromodulation for neurogenic bladder. Current Bladder Dysfunction Reports. 2013;**8**(4):282-288

[10] Daneshgari F, Moy ML. Current indications for neuromodulation. The Urologic Clinics of North America.

[11] Al-zahrani AA, Elzayat EA, Gajewski JB. Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms: 14-year experience at 1 center. The Journal of

Urology. 2011;**185**(3):981-986

[12] Elterman DS, Chughtai B, Vertosick E, Thomas D, Eastham J, Sandhu J. Trends and clinical practice patterns of sacral neuromodulation for overactive bladder. Female Pelvic Medicine & Reconstructive Surgery.

2018;**24**(4):264-266

2014;**25**(1):33-46

[13] Suskind AM, Dunn RL, Kaufman SR, DeLancey JO, Clemens JQ, Stoffel JT, et al. Understanding the dissemination of sacral neuromodulation. Surgical Innovation. 2013;**20**(6):625-630

[14] Laviana A, Jellison F, Kim JH. Sacral neuromodulation for refractory overactive bladder, interstitial cystitis, and painful bladder syndrome.

[15] Abello A, Das AK. Electrical neuromodulation in the management of lower urinary tract dysfunction: Evidence, experience and future prospects. Therapeutic Advances in

Urology. 2018;**10**(5):165-173

[16] Malde S, Fry C, Schurch B, Marcelissen T, Averbeck M, Digesu A, et al. What is the exact working mechanism of botulinum toxin a and sacral nerve stimulation in

Neurosurgery Clinics of North America.

2005;**32**(1):37-40, vi

*DOI: http://dx.doi.org/10.5772/intechopen.92287*

[1] Li LF, Ka-Kit Leung G, Lui WM. Sacral nerve stimulation for neurogenic bladder. World Neurosurgery. 2016;**90**:

[3] Tanagho EA, Schmidt RA. Electrical stimulation in the clinical management of the neurogenic bladder. The Journal of Urology. 1988;**140**(6):1331-1339

International continence society best practice statement for use of sacral neuromodulation. Neurourology and Urodynamics. 2018;**37**(5):1823-1848

[6] Brindley GS. An implant to empty the bladder or close the urethra. Journal of Neurology, Neurosurgery, and Psychiatry. 1977;**40**(4):358-369

Rushton DN, Cardozo L. Sacral anterior root stimulators for bladder control in paraplegia: The first 50 cases. Journal of Neurology, Neurosurgery, and Psychiatry. 1986;**49**(10):1104-1114

Fischer J, Madersbacher H, Polkey CE,

[7] Brindley GS, Polkey CE,

[8] Sauerwein D, Ingunza W,

Brindley GS, et al. Extradural implantation of sacral anterior root stimulators. Journal of Neurology, Neurosurgery, and Psychiatry.

1990;**53**(8):681-684

[2] Schmidt RA. Applications of neurostimulation in urology. Neurourology and Urodynamics. 1988;**7**:585-592. DOI: 10.1002/nau.

[4] Goldman HB, Lloyd JC, Noblett KL, Carey MP, Castano Botero JC, Gajewski JB, et al.

[5] Janssen DA, Martens FM, de Wall LL, van Breda HM, Heesakkers JP. Clinical utility of neurostimulation devices in the treatment of overactive bladder: Current perspectives. Medical Devices (Auckland, N.Z.). 2017;**10**:109-122

236-243

**References**

1930070607

*Neuromodulation in Urology: Current Trends and Future Applications DOI: http://dx.doi.org/10.5772/intechopen.92287*
